Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018
This report describes declines in HPV vaccine-type infection prevalence among females when compared with prevalence before vaccination. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - March 25, 2021 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news

HPV vaccine not cost-effective for adults age 26 to 45, study finds
Vaccination against human papillomavirus provides limited health benefits for adults aged 26 years and older at a high cost to the healthcare system, according to a study published Thursday by PLOS Medicine. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 11, 2021 Category: Consumer Health News Source Type: news

HPV vaccines for adults over age 26 may not be cost-effective
(Harvard T.H. Chan School of Public Health) Two simulation models suggest that vaccinating adults older than age 26 against human papillomavirus (HPV) would provide limited health benefit, at a substantial cost (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 11, 2021 Category: Cancer & Oncology Source Type: news

HPV vaccine may not be cost-effective in adult populations aged over 26 years
This study suggests that HPV vaccination over age 26 years provides limited health benefits at a high cost. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 11, 2021 Category: Cancer & Oncology Source Type: news

St. Jude launches program to boost HPV cancer prevention across the globe
(St. Jude Children's Research Hospital) St. Jude is dedicating staff and resources to focus on the prevention of human papillomavirus (HPV)-related cancers around the world through HPV vaccine awareness programming. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 4, 2021 Category: Cancer & Oncology Source Type: news

Rwanda: Covid-19 - Pandemic Halts HPV Vaccination in Kigali
[New Times] Several challenges related to the Covid-19 pandemic have frustrated plans to roll out a vaccination programme aimed at eliminating cervical cancer causing Human Papillomavirus (HPV) for girls aged 12, The New Times can exclusively reveal. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 18, 2021 Category: African Health Source Type: news

Parental HPV Vaccine Hesitancy Increased During 2012 to 2018
TUESDAY, Feb. 9, 2021 -- From 2012 to 2018, there was an increase in the proportion of unvaccinated adolescents who received a recommendation for human papillomavirus (HPV) vaccination, but parental HPV vaccine hesitancy also increased, according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 9, 2021 Category: Pharmaceuticals Source Type: news

More Parents Balking at Giving Kids Cancer-Fighting HPV Vaccine
TUESDAY, Feb. 9, 2021 -- Although more teens are getting the human papillomavirus (HPV) vaccine, parents ' hesitancy is growing, a new study finds. From 2012 to 2018, more doctors recommended their patients get vaccinated with the HPV vaccine --... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 9, 2021 Category: General Medicine Source Type: news

HPV vaccine study shows major geographic disparities in people receiving or completing doses to fight the cancer-causing disease
The human papillomavirus is the most common cause of cervical cancer. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - January 31, 2021 Category: Consumer Health News Authors: Erin Blakemore Source Type: news

We All Deserve Protection From Covid-19
Credit: United NationsBy Adaora OkoliNEW ORLEANS, US, Dec 11 2020 (IPS) When I contracted Ebola virus disease in August 2014 while working as a medical doctor in a well-known private hospital in Lagos, Nigeria, I was denied access to a potential cure. For 15 days, I battled for my life in a debilitated isolation ward, not knowing if I would survive. But American aid workers who contracted Ebola were administered Zmapp, a monoclonal antibody treatment, which reduces the relative risk of death from Ebola by 40% as well as shorten the duration of stay in the Ebola treatment units. They survived. We were told that Zmapp was e...
Source: IPS Inter Press Service - Health - December 11, 2020 Category: International Medicine & Public Health Authors: Adaora Okoli Tags: Headlines Health TerraViva United Nations Source Type: news

Increasing HPV vaccine uptake in adolescents
(University of Pennsylvania School of Nursing) More than 90 percent of human papillomavirus (HPV)-related cancers could be prevented by widespread uptake of the HPV vaccine. Yet, vaccine use in the United States falls short of public health goals. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 1, 2020 Category: Cancer & Oncology Source Type: news

Uganda: Uganda Yet to Embrace Hpv Vaccination
[Monitor] he magic bullet to stop the infamous cervical cancer rise, according to experts lies in Human papillomavirus (HPV) vaccination. Countries have since launched several vaccination campaigns as recommended by different world health bodies and specific organisations in the cancer battle. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 23, 2020 Category: African Health Source Type: news

Interventions to Increase HPV Vaccine Coverage Cost-Effective
MONDAY, Nov. 16, 2020 -- Three interventions for increased human papillomavirus (HPV) vaccine coverage are cost-effective, according to a study published online Nov. 16 in Pediatrics. Jennifer C. Spencer, Ph.D., from the Harvard T.H. Chan School of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2020 Category: Pharmaceuticals Source Type: news

Black College Students, Especially Women, Delay HPV Vaccination Black College Students, Especially Women, Delay HPV Vaccination
The human papillomavirus (HPV) disproportionately affects people of color and Black gay men, yet many within these communities do not receive the HPV vaccine, most notably college-aged women of color.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - November 15, 2020 Category: Infectious Diseases Tags: Nursing News Source Type: news

HPV Vaccine Generally Well Tolerated in Males
WEDNESDAY, Nov. 4, 2020 -- Human papillomavirus (HPV) vaccines are safe and well tolerated in males, with few reports of adverse events, according to a study published online Nov. 3 in the British Journal of Clinical Pharmacology. Giulia Bonaldo,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 4, 2020 Category: Pharmaceuticals Source Type: news